Cargando...
CRMP2 phosphorylation drives glioblastoma cell proliferation
Glioblastoma (GBM) is an aggressive primary brain tumor. The rapid growth and the privileged provenance of the tumor within the brain contribute to its aggressivity and poor therapeutic targeting. A poor prognostic factor in glioblastoma is the deletion or mutation of the Nf1 gene. This gene codes f...
Gardado en:
| Publicado en: | Mol Neurobiol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5745298/ https://ncbi.nlm.nih.gov/pubmed/28660485 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12035-017-0653-9 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|